We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GSHD:NASDAQGoosehead Insurance, Inc. Analysis

Data as of 2026-04-07 - not real-time

$44.49

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Goosehead Insurance (GSHD) is trading at $44.49, comfortably above its DCF‑derived fair value of $26.44, indicating a significant premium. The stock sits just above its 20‑day SMA ($43.52) but remains well under the 50‑day ($50.65) and 200‑day ($72.73) averages, underscoring a bearish medium‑term trend. Technical signals are mixed: RSI is neutral at 46, the MACD histogram is positive (bullish) while the overall trend is classified as bearish and volume is on a decreasing trajectory, suggesting weakening momentum. Volatility is high at 56.7% over the past 30 days and beta (0.74) points to modest market sensitivity, yet the recent price action reflects heightened risk.
Fundamentally, the company posted 12.2% revenue growth and maintains a solid operating margin (29.3%) with strong cash generation (operating cash flow $91.8M). Forward EPS is projected at $2.66, compressing the forward P/E to 16.7, closer to the industry average (16.7). However, the balance sheet shows a large debt load ($352M) against negligible equity (negative book value per share), and the PE of 42.8 versus the sector’s 16.7 signals overvaluation. Recent material news includes a new General Counsel appointment, RBC Capital’s initiation of coverage with a "Sector Perform" rating, and management’s discussion of buybacks to fund tech‑driven growth, all of which could influence investor sentiment.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price trading above 20‑day SMA but below longer‑term averages
  • Decreasing volume and high 30‑day volatility
  • Current price far exceeds DCF fair value, indicating overvaluation

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue growth of 12% and strong operating margins
  • Forward P/E compressing toward industry norms
  • Persistent bearish technical trend and elevated debt levels

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustained cash generation and positive earnings outlook
  • Strategic buyback program and tech‑driven growth initiatives
  • Negative book value and high historical drawdown limiting upside

Key Metrics & Analysis

Financial Health

Revenue Growth12.20%
Profit Margin7.63%
P/E Ratio42.8
ROA12.07%
P/B Ratio-11.5
Op. Cash Flow$91.8M
Free Cash Flow$57.3M
Industry P/E16.7

Technical Analysis

TrendBearish
RSI46.2
Support$40.00
Resistance$49.65
MA 20$43.52
MA 50$50.65
MA 200$72.73
MACDBullish
VolumeDecreasing
Fear & Greed Index76.5

Valuation

Fair Value$26.44
Target Price$73.00
Upside/Downside64.08%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.74
Volatility56.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.